연구성과로 돌아가기
JCR 2024 저널 목록 (690 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journal of Clinical Neurology | KOREAN NEUROLOGICAL ASSOC | 1738-6586 | 2005-5013 | SCIE | CLINICAL NEUROLOGY | 2,337 | 3.1 | Q2 | 34.6 | 65.4 | 99/285 | 2.9 | Q2 | 2.9 | 0.9 | 0.77 | 124/285 | Q2 | 56.67 | 0.002 | 0.470 | 0.842 | Q3 | 54 | 90.7% | 6.9 | 8.8 | 49 | 100.0% | 2025-08-05 16:02:42 | 바로가기 |
| JOURNAL OF NEURO-ONCOLOGY | SPRINGER | 0167-594X | 1573-7373 | SCIE | CLINICAL NEUROLOGY | 14,727 | 3.1 | Q2 | 34.6 | 65.4 | 99/285 | 3.6 | Q2 | 2.8 | 0.7 | 0.81 | 108/285 | Q2 | 62.28 | 0.012 | 2.607 | 1.059 | Q2 | 329 | 83.3% | 7.9 | 6.6 | 274 | 31.5% | 2025-08-05 16:02:42 | 바로가기 |
| Journal of Neuroimmune Pharmacology | SPRINGER | 1557-1890 | 1557-1904 | SCIE | NEUROSCIENCES | 3,337 | 3.5 | Q2 | 34.6 | 65.4 | 109/314 | 5.1 | Q1 | 3.4 | 1.2 | 1.10 | 77/314 | Q1 | 75.64 | 0.003 | 0.572 | 1.306 | Q2 | 56 | 92.9% | 7.9 | 7.0 | 52 | 31.2% | 2025-08-05 16:04:19 | 바로가기 |
| JOURNAL OF NEUROSURGERY-SPINE | AMER ASSOC NEUROLOGICAL SURGEONS | 1547-5654 | 1547-5646 | SCIE | CLINICAL NEUROLOGY | 10,362 | 3.1 | Q2 | 34.6 | 65.4 | 99/285 | 3.4 | Q2 | 2.8 | 0.9 | 1.21 | 52/285 | Q1 | 81.93 | 0.009 | 2.017 | 1.076 | Q2 | 162 | 88.9% | 8.3 | 7.4 | 144 | 2.1% | 2025-08-05 16:02:42 | 바로가기 |
| JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY | LIPPINCOTT WILLIAMS & WILKINS | 0898-4921 | 1537-1921 | SCIE | ANESTHESIOLOGY | 1,821 | 2.4 | Q2 | 34.6 | 65.4 | 24/68 | 2.4 | Q2 | 2.2 | 1.5 | 1.09 | 15/68 | Q1 | 78.68 | 0.001 | 0.314 | 0.686 | Q2 | 55 | 94.6% | 8.6 | 7.1 | 52 | 2.8% | 2025-08-05 16:02:26 | 바로가기 |
| Journal of Obstetrics and Gynaecology Canada | ELSEVIER INC | 1701-2163 | 1701-2163 | ESCI | OBSTETRICS & GYNECOLOGY | 3,720 | 2.2 | Q2 | 34.6 | 65.4 | 49/140 | 2.0 | Q3 | 2.0 | 0.5 | 0.68 | 69/140 | Q2 | 51.07 | 0.004 | 0.869 | 0.702 | Q2 | 146 | 91.8% | 7.2 | 8.0 | 134 | 12.6% | 2025-08-05 16:04:22 | 바로가기 |
| Journal of Pregnancy | WILEY | 2090-2727 | 2090-2735 | ESCI | OBSTETRICS & GYNECOLOGY | 945 | 2.2 | Q2 | 34.6 | 65.4 | 49/140 | 2.9 | Q2 | 2.1 | 0.3 | 0.99 | 34/140 | Q1 | 76.07 | 0.001 | 0.150 | 0.679 | Q2 | 24 | 79.2% | 7.2 | 6.0 | 19 | 100.0% | 2025-08-05 16:04:23 | 바로가기 |
| Korean Journal of Pain | KOREAN PAIN SOC | 2005-9159 | 2093-0569 | SCIE | CLINICAL NEUROLOGY | 1,296 | 3.1 | Q2 | 34.6 | 65.4 | 99/285 | 3.1 | Q2 | 2.8 | 1.4 | 0.91 | 87/285 | Q2 | 69.65 | 0.001 | 0.265 | 0.743 | Q3 | 31 | 67.7% | 5.6 | 7.2 | 21 | 100.0% | 2025-08-05 16:02:42 | 바로가기 |
| METABOLIC BRAIN DISEASE | SPRINGER/PLENUM PUBLISHERS | 0885-7490 | 1573-7365 | SCIE | NEUROSCIENCES | 6,345 | 3.5 | Q2 | 34.6 | 65.4 | 109/314 | 3.6 | Q2 | 3.4 | 0.3 | 0.81 | 140/314 | Q2 | 55.57 | 0.005 | 1.204 | 0.710 | Q3 | 161 | 79.5% | 5.4 | 7.1 | 128 | 10.4% | 2025-08-05 16:04:18 | 바로가기 |
| MOLECULAR GENETICS AND METABOLISM | ACADEMIC PRESS INC ELSEVIER SCIENCE | 1096-7192 | 1096-7206 | SCIE | MEDICINE, RESEARCH & EXPERIMENTAL | 8,343 | 3.5 | Q2 | 34.6 | 65.4 | 68/195 | 3.8 | Q2 | 3.2 | 1.0 | 0.78 | 73/195 | Q2 | 62.82 | 0.006 | 1.251 | 1.159 | Q2 | 120 | 84.2% | 9.5 | 8.2 | 101 | 38.5% | 2025-08-05 16:04:10 | 바로가기 |
| Molecular Medicine Reports | SPANDIDOS PUBL LTD | 1791-2997 | 1791-3004 | SCIE | MEDICINE, RESEARCH & EXPERIMENTAL | 26,534 | 3.5 | Q2 | 34.6 | 65.4 | 68/195 | 3.2 | Q2 | 3.5 | 1.4 | 0.78 | 73/195 | Q2 | 62.82 | 0.016 | 3.515 | 0.606 | Q3 | 181 | 69.6% | 6.6 | 6.4 | 126 | 82.5% | 2025-08-05 16:04:10 | 바로가기 |
| MUSCLE & NERVE | WILEY | 0148-639X | 1097-4598 | SCIE | CLINICAL NEUROLOGY | 13,874 | 3.1 | Q2 | 34.6 | 65.4 | 99/285 | 3.2 | Q2 | 2.8 | 0.6 | 0.81 | 108/285 | Q2 | 62.28 | 0.008 | 1.780 | 0.971 | Q2 | 214 | 89.2% | 11.4 | 9.1 | 191 | 32.0% | 2025-08-05 16:02:42 | 바로가기 |
| NEUROBIOLOGY OF AGING | ELSEVIER SCIENCE INC | 0197-4580 | 1558-1497 | SCIE | NEUROSCIENCES | 22,708 | 3.5 | Q2 | 34.6 | 65.4 | 109/314 | 4.1 | Q2 | 3.3 | 0.8 | 0.97 | 99/314 | Q2 | 68.63 | 0.013 | 2.951 | 1.336 | Q2 | 128 | 98.4% | 10.6 | 9.6 | 126 | 40.3% | 2025-08-05 16:04:18 | 바로가기 |
| NEUROLOGIA | ELSEVIER ESPANA SLU | 0213-4853 | 1578-1968 | SCIE | CLINICAL NEUROLOGY | 2,226 | 3.1 | Q2 | 34.6 | 65.4 | 99/285 | 2.9 | Q2 | 3.0 | 1.3 | 0.81 | 108/285 | Q2 | 62.28 | 0.002 | 0.437 | 0.760 | Q3 | 83 | 81.9% | 6.4 | 9.5 | 68 | 98.7% | 2025-08-05 16:02:42 | 바로가기 |
| NEUROMODULATION | ELSEVIER | 1094-7159 | 1525-1403 | SCIE | MEDICINE, RESEARCH & EXPERIMENTAL | 5,243 | 3.5 | Q2 | 34.6 | 65.4 | 68/195 | 3.5 | Q2 | 3.2 | 1.5 | 0.98 | 50/195 | Q2 | 74.62 | 0.006 | 1.256 | 0.950 | Q2 | 132 | 86.4% | 5.5 | 8.7 | 114 | 28.9% | 2025-08-05 16:04:10 | 바로가기 |
페이지 이동: